- Home
- Publications
- Publication Search
- Publication Details
Title
Management of glioblastoma: State of the art and future directions
Authors
Keywords
-
Journal
CA-A CANCER JOURNAL FOR CLINICIANS
Volume 70, Issue 4, Pages 299-312
Publisher
Wiley
Online
2020-06-01
DOI
10.3322/caac.21613
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial
- (2020) David A. Reardon et al. CLINICAL CANCER RESEARCH
- Association of Maximal Extent of Resection of Contrast-Enhanced and Non–Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma
- (2020) Annette M. Molinaro et al. JAMA Oncology
- Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial
- (2019) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of larotrectinib in TRK fusion cancer patients with brain metastases or primary central nervous system tumors.
- (2019) Alexander E. Drilon et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized phase IIb clinical trial of continuation or non-continuation with six cycles of temozolomide after the first six cycles of standard first-line treatment in patients with glioblastoma: A Spanish research group in neuro-oncology (GEINO) trial.
- (2019) Carmen Balana et al. JOURNAL OF CLINICAL ONCOLOGY
- Environmental risk factors of primary brain tumors: A review
- (2019) A. Vienne-Jumeau et al. REVUE NEUROLOGIQUE
- Longitudinal molecular trajectories of diffuse glioma in adults
- (2019) Floris P. Barthel et al. NATURE
- ACTR-21. A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF DEPATUXIZUMAB MAFODOTIN (ABT-414) IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFIED (AMP) NEWLY DIAGNOSED GLIOBLASTOMA (nGBM)
- (2019) Andrew Lassman et al. NEURO-ONCOLOGY
- Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study
- (2018) D Gramatzki et al. ANNALS OF ONCOLOGY
- Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas
- (2018) Sherise D Ferguson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
- (2018) Linda M. Liau et al. Journal of Translational Medicine
- Current state of immunotherapy for glioblastoma
- (2018) Michael Lim et al. Nature Reviews Clinical Oncology
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma
- (2018) Martin J. B. Taphoorn et al. JAMA Oncology
- Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014
- (2018) Quinn T. Ostrom et al. JAMA Oncology
- Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma
- (2018) Rimas V. Lukas et al. JOURNAL OF NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
- (2018) Quinn T Ostrom et al. NEURO-ONCOLOGY
- BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study
- (2018) Thomas Kaley et al. JOURNAL OF CLINICAL ONCOLOGY
- Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial
- (2018) Giuseppe Lombardi et al. LANCET ONCOLOGY
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Brain Tumor Imaging
- (2017) Kevin M. Brindle et al. JOURNAL OF CLINICAL ONCOLOGY
- The involvement of thrombin in the pathogenesis of glioblastoma
- (2017) Harald Krenzlin et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma
- (2017) Andrea Pace et al. LANCET ONCOLOGY
- Glioblastoma in elderly patients: solid conclusions built on shifting sand?
- (2017) Antje Wick et al. NEURO-ONCOLOGY
- Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location
- (2017) Michael Karremann et al. NEURO-ONCOLOGY
- P14.19 Preclinical and clinical efficacy of entrectinib in primary and metastatic brain tumors harboring NTRK, ROS1, or ALK gene fusions
- (2017) S. Rangaraju et al. NEURO-ONCOLOGY
- Global incidence of malignant brain and other central nervous system tumors by histology, 2003–2007
- (2017) Rebecca Leece et al. NEURO-ONCOLOGY
- NovoTTF: where to go from here?
- (2017) Timothy F. Cloughesy et al. NEURO-ONCOLOGY
- OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143
- (2017) D. A. Reardon et al. NEURO-ONCOLOGY
- Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
- (2017) James R. Perry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lomustine and Bevacizumab in Progressive Glioblastoma
- (2017) Wolfgang Wick et al. NEW ENGLAND JOURNAL OF MEDICINE
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients
- (2016) Christine Jungk et al. BMC CANCER
- Corticosteroids compromise survival in glioblastoma
- (2016) Kenneth L. Pitter et al. BRAIN
- Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study
- (2016) E. S. Amirian et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)
- (2016) W. Wick et al. CLINICAL CANCER RESEARCH
- Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma
- (2016) Jayashree Kalpathy-Cramer et al. JOURNAL OF NEURO-ONCOLOGY
- Maximizing safe resection of low- and high-grade glioma
- (2016) Shawn L. Hervey-Jumper et al. JOURNAL OF NEURO-ONCOLOGY
- Tumor treating fields: a novel treatment modality and its use in brain tumors
- (2016) Andreas F. Hottinger et al. NEURO-ONCOLOGY
- Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial
- (2016) Bogdana Suchorska et al. NEURO-ONCOLOGY
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of the Extent of Resection With Survival in Glioblastoma
- (2016) Timothy J. Brown et al. JAMA Oncology
- Glioblastoma: pathology, molecular mechanisms and markers
- (2015) Kenneth Aldape et al. ACTA NEUROPATHOLOGICA
- Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma
- (2015) A. L. Di Stefano et al. CLINICAL CANCER RESEARCH
- MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
- (2015) M. Weller et al. CLINICAL CANCER RESEARCH
- BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial
- (2015) Stuart H. Burri et al. JOURNAL OF NEURO-ONCOLOGY
- Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis
- (2015) Sajeel A. Chowdhary et al. JOURNAL OF NEURO-ONCOLOGY
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort
- (2015) Johan Pallud et al. NEURO-ONCOLOGY
- Immunosuppressive mechanisms in glioblastoma: Fig. 1.
- (2015) Edjah K. Nduom et al. NEURO-ONCOLOGY
- Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection
- (2015) Florian Ringel et al. NEURO-ONCOLOGY
- Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
- (2015) Jeanette E. Eckel-Passow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Second-Line Chemotherapy in Recurrent Glioblastoma: A 2-Cohort Study
- (2015) Bruno F. Carvalho et al. Oncology Research and Treatment
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2015) Gary H. Lyman et al. Journal of Oncology Practice
- Molecular stereotactic biopsy technique improves diagnostic accuracy and enables personalized treatment strategies in glioma patients
- (2014) Sabina Eigenbrod et al. ACTA NEUROCHIRURGICA
- Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma
- (2014) S Han et al. BRITISH JOURNAL OF CANCER
- Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors
- (2014) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- Medical management of brain tumors and the sequelae of treatment
- (2014) D. Schiff et al. NEURO-ONCOLOGY
- Survival effect of first- and second-line treatments for patients with primary glioblastoma: a cohort study from a prospective registry, 1997-2010
- (2014) F. Nava et al. NEURO-ONCOLOGY
- TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas
- (2014) Matthias Simon et al. NEURO-ONCOLOGY
- A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K
- (2014) Daniel J. Ma et al. NEURO-ONCOLOGY
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- The landscape of kinase fusions in cancer
- (2014) Nicolas Stransky et al. Nature Communications
- Epithelioid GBMs Show a High Percentage of BRAF V600E Mutation
- (2013) Bette Kay Kleinschmidt-DeMasters et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data
- (2013) Nameeta Shah et al. BMC GENOMICS
- Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy
- (2013) Michael Weller et al. INTERNATIONAL JOURNAL OF CANCER
- Concurrent Stereotactic Radiosurgery and Bevacizumab in Recurrent Malignant Gliomas: A Prospective Trial
- (2013) Alvin R. Cabrera et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma
- (2013) Tracy T. Batchelor et al. JOURNAL OF CLINICAL ONCOLOGY
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
- (2013) Mark R. Gilbert et al. JOURNAL OF CLINICAL ONCOLOGY
- Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis
- (2013) Abraham Noorbakhsh et al. JOURNAL OF NEUROSURGERY
- BRAF-V600E mutation in pediatric and adult glioblastoma
- (2013) S. Dahiya et al. NEURO-ONCOLOGY
- Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma
- (2013) Kaisorn L. Chaichana et al. NEURO-ONCOLOGY
- A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07)
- (2013) Markus Hutterer et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
- (2013) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations
- (2012) Xiao-Yang Liu et al. ACTA NEUROPATHOLOGICA
- The Definition of Primary and Secondary Glioblastoma
- (2012) H. Ohgaki et al. CLINICAL CANCER RESEARCH
- NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
- (2012) Roger Stupp et al. EUROPEAN JOURNAL OF CANCER
- Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
- (2012) Annika Malmström et al. LANCET ONCOLOGY
- Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
- (2012) Wolfgang Wick et al. LANCET ONCOLOGY
- Thromboembolic disease in patients with high-grade glioma
- (2012) J. R. Perry NEURO-ONCOLOGY
- Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
- (2012) D. Singh et al. SCIENCE
- The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review
- (2011) Sanjay Dixit et al. BRITISH JOURNAL OF NEUROSURGERY
- Bevacizumab and daily temozolomide for recurrent glioblastoma
- (2011) Annick Desjardins et al. CANCER
- Improved survival time trends for glioblastoma using the SEER 17 population-based registries
- (2011) Matthew Koshy et al. JOURNAL OF NEURO-ONCOLOGY
- Glioblastoma survival in the United States before and during the temozolomide era
- (2011) Derek R. Johnson et al. JOURNAL OF NEURO-ONCOLOGY
- Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial
- (2011) Christian Senft et al. LANCET ONCOLOGY
- A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
- (2011) J. J. Raizer et al. NEURO-ONCOLOGY
- Familial Aggregation of Glioma: A Pooled Analysis
- (2010) M. E. Scheurer et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
- (2010) Houtan Noushmehr et al. CANCER CELL
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Radiation Dose–Volume Effects in the Brain
- (2010) Yaacov Richard Lawrence et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
- (2010) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas
- (2010) Shannon E. Fogh et al. JOURNAL OF CLINICAL ONCOLOGY
- A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures
- (2010) Justin B. Usery et al. JOURNAL OF NEURO-ONCOLOGY
- Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study
- (2010) Walter Stummer et al. JOURNAL OF NEUROSURGERY
- PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma
- (2010) J. R. PERRY et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study
- (2010) W. K. A. Yung et al. NEURO-ONCOLOGY
- Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)
- (2010) F. M. Iwamoto et al. NEURO-ONCOLOGY
- Symptoms and problems in the end-of-life phase of high-grade glioma patients
- (2010) E. M. Sizoo et al. NEURO-ONCOLOGY
- Functional Magnetic Resonance Imaging and Diffusion Tensor Tractography Incorporated Into an Intraoperative 3-Dimensional Ultrasound-Based Neuronavigation System
- (2010) Erik Magnus Berntsen et al. NEUROSURGERY
- Review on Quality of Life Issues in Patients with Primary Brain Tumors
- (2010) M. J. B. Taphoorn et al. ONCOLOGIST
- Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas
- (2009) Philip H. Gutin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of anti-epileptic drugs in patients with gliomas and seizures
- (2009) Mèlanie S. M. Breemen et al. JOURNAL OF NEUROLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- The interface between glial progenitors and gliomas
- (2008) Peter Canoll et al. ACTA NEUROPATHOLOGICA
- Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human Gliomas
- (2008) A. B. Heimberger et al. CLINICAL CANCER RESEARCH
- Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- (2008) Michael D. Prados et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Promoter Methylation and Polymorphisms of the MGMT Gene in Glioblastomas: A Population-Based Study
- (2008) Izabela Zawlik et al. NEUROEPIDEMIOLOGY
- Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study
- (2007) Amy B. Heimberger et al. NEURO-ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now